In September 2023, MeDomino's leading product, MeDomino Content Hub, was officially approved by the China National Intellectual Property Administration as a registered trademark. The underlying technology of MeDomino Content Hub also passed CNIPA review more than a month ago, receiving patent rights and an invention patent certificate.
This patented invention is the core capability of MeDomino Content Hub: content tagging. With precise tags, large volumes of dispersed, multi-format content can be coordinated and managed centrally, enabling efficient reuse.
MeDomino Content Hub was created specifically for content management in the pharma and medtech industry. It belongs to the key software field within the "six industrial foundations." It solves long-standing pain points that have troubled pharma and medtech companies, including large content volumes, dispersed storage, messy content formats, difficulty in centralized management, difficulty forming enterprise-level knowledge bases, and difficulty with precise reuse. It fills a gap in the digital marketing field for the pharma and medtech industry.
In the future, MeDomino will continue insisting on technological innovation and keep improving product capabilities, helping the pharma and medtech industry effectively reduce marketing costs, improve operating efficiency, develop legally and compliantly, and contribute to the smooth advancement of Healthy China 2030.
